Ionis Pharmaceuticals | IONS - 流动负债



金融业
股票价格
USD
资产
USD 2.99B
现金及等价物
USD 350.07M
销售成本
USD 2.74M
流动资产
USD 2.49B
流动负债
USD 315.64M
债务
USD 1.91B
EBIT
USD -102.29M
EBITDA
USD -64.53M
员工
1.07K
EPS每股收益
USD -0.69
股本和储备
USD 439.74M
销售毛利
USD 265M
债务利息支出
USD 18M
利息收入
USD -0.66
贷款资金
USD 1.91B
市值
USD 7.9B
净收入
USD -114.65M
营业费用
USD 370.24M
营业利润
USD -102.29M
普通股股本
USD 165.64M
PE价格收益
396.15
税前利润
USD -114M
销售收入
USD 268M
销售和管理费用
USD 130.08M
股票
USD 50.83M
贸易债权人
USD 47.7M
应收帐款人
USD 58.85M


流动负债 更改 日
Agios Pharmaceuticals USD 70.22M 11.37M 2026-06
Alnylam Pharmaceuticals USD 1.51B 163.04M 2026-06
Arrowhead Research USD 283.35M 11.87M 2026-06
Astellas Pharma JPY 1.23T 16.36B 2026-06
BioCryst Pharmaceuticals USD 208.85M 13.46M 2026-06
BioMarin Pharmaceutical USD 1.66B 870.84M 2026-06
Celltrion KRW 292.71B 9.09B 2026-03
Cspc Pharmaceutical CNY 10.18B 65.36M 2025-12
Deva Holding AS TRY 6.43B 1.18B 2023-09
Divis Laboratories Ltd INR 20.43B 3.15B 2026-03
Exelixis USD 370.98M 34.67M 2026-03
Halozyme Therapeutics USD 344.44M 18.77M 2026-06
Ionis Pharmaceuticals USD 315.64M 401.36M 2026-06
Kangmei Pharma CNY 5.38B 433.79M 2026-03
Knight Therapeutics CAD 165.26M 12.58M 2025-12
Laboratorios Farma EUR 199.84M 121.75M 2023-12
Malin Corporation EUR 1000K 500K 2024-12
Medical Developments International AUD 5.56M 2.26M 2025-12
Moderna USD 2.53B 139M 2026-06
Nektar Therapeutics USD 57.71M 4.17M 2026-03
Neuren Pharmaceuticals AUD 4.34M 3.58M 2025-12
Neurocrine Biosciences USD 874.5M 42.8M 2026-06
Novartis USD 31.75B 374M 2026-06
Omeros USD 85.5M 2.28M 2025-06
OPKO Health USD 148.38M 1.71M 2026-03
Organigram Holdings CAD 88.74M 5.31M 2026-03
Ovoca Bio EUR 1.3M 1.11M 2025-12
Pfizer USD 32.65B 1.7B 2026-06
Pharma Mar EUR 98.42M 9.2M 2026-06
PTC Therapeutics USD 771.07M 152.54M 2026-06
Qiagen NV USD 479.11M 33.03M 2026-03
Regeneron Pharmaceuticals USD 5.53B 422.9M 2026-06
Roche Holding CHF 28.85B 846M 2026-06
Sarepta Therapeutics USD 502.91M 3.74M 2026-06
Sartorius EUR 1.44B 668.7M 2026-06
Sino Biopharmaceutical CNY 24.85B 5.29B 2025-06
Tilray USD 259.32M 8.32M 2025-09
Ultragenyx Pharmaceutical USD 351M 26M 2026-06
Vertex Pharmaceuticals USD 3.94B 57.3M 2026-06
Zealand Pharma A/S 404M 260.96M 2026-03
Zz Pientze Pharmaceu CNY 2.28B 134.52M 2026-03